Recent Class Action Lawsuit Filed Against Lantheus Holdings: Important Updates for Investors

Investor Alert: Class Action Lawsuit Against Lantheus Holdings, Inc.

The Pomerantz Law Firm has recently announced the initiation of a class action lawsuit targeting Lantheus Holdings, Inc. (NASDAQ: LNTH). The firm is reaching out to investors who have incurred losses due to their investments in Lantheus, urging them to consider joining the action. The lawsuit raises concerns over potential securities fraud and other unlawful business practices allegedly conducted by Lantheus and certain of its executive officers and directors.

The Background

The focus of this class action stems from events leading up to significant drops in Lantheus's stock price following disappointing financial reports. On May 7, 2025, the company disclosed its first-quarter financial results, which did not meet market expectations. Notably, sales of its radiopharmaceutical oncology product, Pylarify, experienced a year-over-year decline attributed to what Lantheus described as a "temporal competitive disruption." This revelation prompted a drastic drop in Lantheus's stock, falling by $24.35 per share (23.23%) to close at $80.49.

Further compounding the situation, a second financial report on August 6, 2025, revealed that the company's second-quarter earnings and revenue figures continued to underperform. Once again, Lantheus reported a reduction in growth projections for Pylarify, citing an 8.3% decline in sales year-over-year. Such announcements drew negative reactions from investors, resulting in a significant decrease in stock price by $20.76 (28.58%) to close at $51.87.

Key Deadlines

Investors affected by Lantheus's stock performance are reminded that they have until November 10, 2025, to request the court appoint them as Lead Plaintiff in this class action. It's crucial for investors who participated in purchasing Lantheus's securities during the class period to take action promptly to protect their rights and potential claims. Interested parties can connect with the Pomerantz Law Firm via their website, providing necessary details to facilitate their involvement in the lawsuit.

About Pomerantz LLP

Established by Abraham L. Pomerantz, widely recognized as the pioneer of securities class actions, Pomerantz LLP has built a strong reputation for advocacy in corporate, securities, and antitrust litigation. With over 85 years of experience, they have fought diligently for the victims of corporate misconduct, resulting in substantial damages awarded to class members.

Taking Action

Investors seeking more information about the class action or those who wish to join are encouraged to reach out to Danielle Peyton at Pomerantz LLP at 646-581-9980 or via email at [email protected]. Inquiries should ideally include your mailing address, phone number, and details regarding the number of shares purchased to streamline the communication process.

For more about Pomerantz LLP and updates related to this case, you can visit Pomerantz Law Firm. It's vital for investors to stay informed and engaged as this case unfolds, especially with the looming deadlines for claiming their rights.